DIGITAL THERAPEUTICS
At Henry Ford Innovations, we are excited about Digital therapeutics and their ability to improve healthcare and reduce cost.

Digital therapeutics are products that use technology to treat and manage disease. They are evidencebased tools that are held to the same high standards and regulatory oversight as traditional medical treatments.

A great example of this is the company Livongo. Livongo monitors blood glucose and allows diabetics to share their data with certified coaches and providers. Patients have more control over their health, and clinicians have more data to drive better outcomes.

In 2020, Livongo was acquired by teledoc for 19 billion. This is reflective of the growing digital therapeutics industry which is projected to be $56 billion dollars by 2025.

At Henry Ford Innovations, we are actively looking to partner and codevelop new digital therapeutics solutions.
If you are working on an exciting innovation in the Digital Therapeutics space, email us at [email protected].